NCT07321899ClinicalTrials.gov
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER
En bref
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Interventionnelle1 186 participants recherchés20 sites1 pays
Catégories
Enregistré dans 1 registre
- ClinicalTrials.govNCT07321899Ouvrir cette fiche sur ClinicalTrials.govSynchronisé la semaine dernière
Une même étude peut être enregistrée dans plusieurs registres. Nous l'affichons une seule fois et renvoyons vers chaque fiche que nous détenons.
Les informations de l'essai sont affichées telles que publiées par le registre, dans leur langue d'origine.
Cette étude vous intéresse ?
Se connecter ou créez un compte pour manifester votre intérêt et suivre cette étude.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2026-01-07; recorded start 2026-09-11
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Present: Participants are randomly assignedAllocation is recorded as randomised
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Present: Uses blinding (masking)A masking level is recorded in the record
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 19 other studies in this databaseCounted from the lead sponsor named in the record (Medtronic Cardiovascular)
- Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
A strong methodological design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation20/20
Participants are randomly allocated between arms
- Blinding7/20
Single-blind
- Control arm15/15
Active-comparator control arm
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 4 sites
- Data monitoring committee7/7
A data monitoring committee is in place
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study: 1,186 participants (target), run at 20 sites.
How this score is built
- Enrolment31/40
1,186 participants (target)
- Site count7/25
4 sites
- Country count0/15
Single country
- Planned duration10/10
Planned over about 179 months
- Sponsor scale4/10
Medtronic Cardiovascular has led 19 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Résumé
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Affections
- Severe Tricuspid Regurgitation
Éligibilité
| Sexe | Tous |
|---|---|
| Âges | 18 Years – Aucun maximum |
| Volontaires sains | Non |
Éligibilité telle qu'elle figure dans le registre
Éligibilité en énoncés simples
Les critères de cette fiche n'ont pas encore été décomposés en énoncés distincts. Le texte du registre ci-dessus est complet et fait foi.
Conception de l'étude
| Type d'étude | Interventionnelle |
|---|---|
| Phase | Sans objet |
| Répartition | Randomisée |
| Modèle d'intervention | PARALLEL |
| Objectif principal | TREATMENT |
| Insu | SINGLE (1) |
| Recrutement | 1 186 participants recherchés |
Promoteur et collaborateurs
- Medtronic Cardiovascular Promoteur
Groupes et interventions
- Medtronic Intrepid™ TTVREXPERIMENTAL
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation.
- Edwards EVOQUE TTVRACTIVE_COMPARATOR
Transcatheter tricuspid valve replacement with Edwards EVOQUE TTVR in patients with severe or greater tricuspid regurgitation.
- Single Arm RegistryEXPERIMENTAL
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation who are not eligible for randomization.
Interventions
- Dispositif Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
Transcatheter Tricuspid Valve Replacement
- Dispositif Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
Transcatheter Tricuspid Valve Replacement
Critères de jugement
Critère de jugement principal
Rate of Major Adverse Events (MAE)
Délai 30-days post-procedure
Critère de jugement principal
Composite Endpoint: All-cause mortality, Heart failure hospitalization, and tricuspid valve reintervention
Délai 1-year post-procedure
Critère de jugement secondaire
Tricuspid regurgitation (TR) grade reduction
Total number of patients with at least one grade TR reduction
Délai 6 months post-procedure
Critère de jugement secondaire
Change in quality of life (QoL) as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) from baseline
KCCQ overall summary score is a patient-reported measure of health status. Scores range from 0 to 100 where higher scores reflect better quality of life
Délai 6 months post-procedure
Critère de jugement secondaire
All-cause mortality
Délai 12 months post-procedure
Critère de jugement secondaire
Heart failure hospitalization
Délai 12 months post-procedure
Critère de jugement secondaire
New onset conduction disturbance (NOCD)
Délai 30 days post-procedure
Critère de jugement secondaire
Total procedure time
Délai Procedure
Critère de jugement secondaire
Right ventricle (RV) dysfunction
Délai 12 months post-procedure
Dates
| Date de début | 11 septembre 2026 (réelle) |
|---|---|
| Achèvement principal | 1 septembre 2031 (estimée) |
| Achèvement | 1 avril 2041 (estimée) |
| Première publication | 7 janvier 2026 (réelle) |
| Dernière mise à jour | 12 novembre 2026 |
| Résultats publiés | Non précisé dans la fiche du registre |
| Statut vérifié pour la dernière fois | novembre 2026 |
Réelle signifie que l'événement a eu lieu. Estimée signifie que le promoteur s'y attend. Les deux ont un sens différent.
Lieux
20 sites sont en recrutement
United States
| Établissement | Ville | État ou région | Statut |
|---|---|---|---|
| Emory University Hospital Midtown | Atlanta | Georgia | En recrutement |
| University of Alabama at Birmingham (UAB) Hospital | Birmingham | Alabama | En recrutement |
| Buffalo General Medical Center | Buffalo | New York | En recrutement |
| Northwestern Memorial Hospital | Chicago | Illinois | En recrutement |
| The Christ Hospital | Cincinnati | Ohio | En recrutement |
| Cleveland Clinic Foundation | Cleveland | Ohio | En recrutement |
| Hartford Hospital | Hartford | Connecticut | En recrutement |
| Cedars Sinai Medical Center | Los Angeles | California | En recrutement |
| Northwell Health North Shore University Hospital | Manhasset | New York | En recrutement |
| Abbott Northwestern Hospital | Minneapolis | Minnesota | En recrutement |
| Morristown Medical Center | Morristown | New Jersey | En recrutement |
| Yale New Haven Hospital | New Haven | Connecticut | En recrutement |
| Montefiore Medical Center | New York | New York | En recrutement |
| NYU Langone Medical Center | New York | New York | En recrutement |
| The Valley Hospital | Paramus | New Jersey | En recrutement |
| Abrazo Arizona Heart Hospital | Phoenix | Arizona | En recrutement |
| Kaiser Permanente San Francisco Medical Center | San Francisco | California | En recrutement |
| Los Robles Hospital & Medical Center | Thousand Oaks | California | En recrutement |
| Ascension Via Christi Saint Francis | Wichita | Kansas | En recrutement |
| Lankenau Institute for Medical Research | Wynnewood | Pennsylvania | En recrutement |
Documents de l'étude
Aucun document n'est lié dans cette fiche du registre.
Évolution au fil du temps
- 12 novembre 2026
Site ajouté
7 sites added (20 total)
1320
- 25 septembre 2026
Site ajouté
9 sites added (13 total)
413
- 28 juillet 2026
Statut modifié
Status changed from Not yet recruiting to Recruiting
NOT_YET_RECRUITINGRECRUITING
- 28 juillet 2026
Recrutement ouvert
Recruitment opened
NOT_YET_RECRUITINGRECRUITING
- 28 juillet 2026
Site ajouté
4 sites added (4 total)
04